|Bid||0.00 x 1800|
|Ask||0.00 x 1800|
|Day's Range||79.60 - 80.61|
|52 Week Range||55.80 - 85.07|
|PE Ratio (TTM)||10.06|
|Earnings Date||Jul 23, 2018 - Jul 27, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||86.00|
Express Scripts is terminating its relationship with CareZone over what it calls a contract dispute. The company says CareZone is misrepresenting itself as a retail pharmacy, even though it actually delivers by mail. CareZone disagrees and has encouraged customers to submit emails voicing their complaints.
Express Scripts' (ESRX) loss of major customers, downbeat 2018 earnings guidance and selling of shares to Cigna make it lower its credibility as an investment pick.
Expect the floodgates to open for M&A activity, pursuant to the court approval granted on June 12 to the $85 billion bid by telecom provider AT&T Inc. ( T) for cable TV giant Time Warner Inc. ( TWX). ...
FILE: The CVS Health Corp. signage is displayed outside a pharmacy store in downtown Los Angeles, California, U.S., on Friday, Oct. 27, 2017. It’s been a good week for CVS Health and Aetna with a judge clearing the AT&T-Time Warner merger and now the nation’s largest doctor group staying quiet on the drugstore chain’s proposed acquisition of the nation’s third-largest health insurance company. Wall Street is cheering a federal judge’s ruling that the U.S. Justice Department failed to prove that AT&T’s $85 billion purchase of Time Warner violated antitrust deals.
Court approval of the AT&T-Time Warner deal now makes it more likely that similar kinds of pending mergers will go through — and there’s a good investing angle in this. The green light in the deal appears to clear the way for CVS Health’s (CVS) planned acquisition of insurer Aetna (AET), and Cigna’s (CI) pending takeover of pharmacy-benefit manager (PBM) Express Scripts (ESRX).
A U.S. District Court approved AT&T Inc. (NYSE: T )'s purchase of Time Warner Inc (NYSE: TWX ) Tuesday and advised the Justice Department not to seek a stay of the ruling. The results were celebrated ...
A federal judge's decision on Tuesday, June 11, to clear the merger of AT&T Inc. "While the cable marketplace is not the same as the [managed care organization-pharmacy benefit manager] marketplace, with the latter seeing third party pay, the decision is favorable for the two large vertical mega-mergers," wrote Leerink Partners LLC analyst Ana Gupte in a note. Shares of Express Scripts rose 4.8% to $83 in morning trading on Wednesday and Cigna's shares were down 0.8% to $177.40.
A federal judge's ruling late Tuesday blessing the AT&T-Time Warner merger raised hopes that the CVS-Aetna and Cigna-Express Scripts deals will win antitrust approval.
While the court's ruling won't help end world hunger or prevent the creation of bad TV shows, it has opened up the door for some hot trades because let's be honest: You're a trader looking for stock picks rather than an investor in search of a stock to double by 2025. Said top drug analyst Ross Muken at ESI Evercore: "As the first major antitrust case under the current administration and the first time the Department of Justice has tried a vertical merger case in ~40 years, the judge's ruling in favor of the T/TWX deal has a positive read-through for the CI-ESRX merger as well as any other MCO-PBM combinations.
Health and Human Services Secretary Alex Azar's testimony on the Hill made it clear the Trump drug pricing blueprint isn't getting much love. In his testimony, Azar reiterated elements of the blueprint, supported the plan and gave a spirited defense of Trump's promise to lower drug prices in the face of pushback from committee members who pointed to a lack of progress on the issue since the President took office. Predictably, Republican committee members mostly presented Azar easy queries and questions that teed up the administration's talking points.
NEW YORK, June 12, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Southern ...
Health care and telecom stock futures responded after a federal judge approved AT&T's merger of Time Warner. Markets await a Fed rate policy decision on Wednesday.
Express Scripts said Wednesday it will collaborate with a health care technology company behind self-service pharmacy kiosks.
ST. LOUIS, June 7, 2018 /PRNewswire/ -- A suite of high-impact, data-driven engagement programs from Express Scripts (ESRX) are simplifying the prescribing experience for physicians and providers, helping them make better clinical and cost-effective decisions with their patients right at the point-of-care. The solutions are part of the industry's most comprehensive effort to champion a simpler pharmacy experience by improving connectivity and easing the administrative burden for physicians and their staff. "Our industry leading technology platforms, powered by data and analytics from billions of claims, are the cornerstones of a physician-minded portfolio of programs and digital tools that streamline and improve the prescribing process," said Lynne Nowak, M.D., Express Scripts Chief Physician Experience Officer.
Insurer CIGNA Corporation (NYSE: CI ) is poised to sustain share gains in the U.S. commercial risk market, according to Goldman Sachs. The Analyst Analyst Stephen Tanal upgraded shares of Cigna from Neutral ...
ST. LOUIS, June 6, 2018 /PRNewswire/ -- Convenience is the new currency among consumers looking for faster, easier, always-accessible services to conform to their daily lives. As a result, the economy's next big evolution may impact how tens of millions of people get their prescription drugs. "Technology -- and a culture shift -- allow us the opportunity to evolve and simplify healthcare services to better accommodate our busy schedules, which in turn can lead to better adherence and outcomes," said Glen Stettin, M.D., Chief Innovation Officer at Express Scripts.
Let’s talk about the popular Express Scripts Holding Company (NASDAQ:ESRX). The company’s shares saw a decent share price growth in the teens level on the NasdaqGS over the last fewRead More...
Cigna CEO David Cordani is game on in trying to shape the future of healthcare. He talks with TheStreet on where he thinks things are headed.
FRANKLIN LAKES, N.J., June 4, 2018 /PRNewswire/ -- Inside Rx today announced an agreement with the Veterans of Foreign Wars of the U.S. (VFW) to offer easy access to its 1.3 million members and their families who can benefit from the free Inside Rx savings card that provides deep discounts to the uninsured and underinsured who pay cash for their prescription medications. The Inside Rx card can be used in any of the more than 40,000 participating pharmacies in the U.S. and offers more than 125 brand-name medications at a savings average of 40 percent, and a robust list of generics with an average of nearly 80 percent off retail*. "We are honored to work with the VFW to provide an important stop-gap measure that may lower the cost of the prescription medications for our veterans," said Leslie Achter, CEO of Inside Rx, a partially owned subsidiary of Express Scripts (ESRX).
Express Scripts (ESRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ST. LOUIS and BALTIMORE, May 31, 2018 /PRNewswire/ -- For any patient with a rare disease, the journey to the right diagnosis and treatment can be long and difficult. On average, it can take 7.6 years and seven different doctors before a patient suffering from the symptoms of a rare disease finally receives a correct diagnosis. Many times, a second opinion from an expert can help resolve clinical questions and bring emotional reassurance to patients struggling with the symptoms of a rare disease.
LONDON, UK / ACCESSWIRE / May 31, 2018 / If you want access to our free earnings report on Express Scripts Holding Co. (NASDAQ: ESRX) ("Express Scripts"), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=ESRX. The Company reported its first quarter fiscal 2018 operating and financial results on May 02, 2018. Additionally, the Company provided guidance for the upcoming quarter.
CVS Health Corp. is buying Aetna Inc., while Cigna Corp. is snapping up Express Scripts Holding Co. As health-care companies vertically integrate with high-priced deals across varied parts of the industry’s supply chain, Walgreens Boots Alliance Inc.(WBA) , its acquisition of rival Rite Aid’s (RAD)nearly 2,000 stores now complete, remains alone at the party. See: U.S. health care is changing in a big way.